-
Signature
-
Sean D. Mersten, Attorney in Fact for Patrick Plewman
-
Issuer symbol
-
DGX
-
Transactions as of
-
18 Feb 2026
-
Net transactions value
-
-$308,118
-
Form type
-
4
-
Filing time
-
20 Feb 2026, 17:13:11 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Plewman Patrick |
SVP for Diagnostic Services |
500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS |
Sean D. Mersten, Attorney in Fact for Patrick Plewman |
20 Feb 2026 |
0001497368 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DGX |
Common Stock |
Award |
$0 |
+1,952 |
+13% |
$0.000000 |
17,333 |
18 Feb 2026 |
Direct |
F1 |
| transaction |
DGX |
Common Stock |
Tax liability |
$51,242 |
-244 |
-1.4% |
$210.01 |
17,089 |
18 Feb 2026 |
Direct |
F2 |
| transaction |
DGX |
Common Stock |
Tax liability |
$60,648 |
-293 |
-1.7% |
$206.99 |
16,796 |
18 Feb 2026 |
Direct |
F2 |
| transaction |
DGX |
Common Stock |
Sale |
$196,227 |
-958 |
-5.7% |
$204.83 |
15,838 |
19 Feb 2026 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
DGX |
Non-Qualifed Stock Option (right to buy) |
Award |
$0 |
+9,009 |
|
$0.000000 |
9,009 |
18 Feb 2026 |
Common Stock |
9,009 |
$204.96 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: